Madam Speaker, once again, I want to thank my colleague opposite for addressing this. It is an important issue on which we all agree here in the House.
The federal government and the provinces and territories are speaking with one voice on MS. The media has been reporting different things, but let us be clear. We all agree that clinical trial will happen in Canada if and when the research supports it, and if the research supports it, funding will be available as well.
We are moving as quickly as possible, based upon the best available science. If the experts advise in favour of clinical trials, our government, working with the MS Society and the provinces and territories, will ensure that they are funded.
Once again, my heart goes out to all those who suffer from this disabling disease. We are going to continue to talk about this. It is a priority.